TMCnet News
Research and Markets: Hepatic (Liver) Tumor Pipeline Insights Report 2015Research and Markets (http://www.researchandmarkets.com/research/dhkjgr/hepatic_liver) has announced the addition of the "Hepatic (Liver) Tumor-Pipeline Insights, 2015" subscription to their offering. This Hepatic Liver Tumor-Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Hepatic Liver Tumor. This report provides information on the therapeutic development based on the Hepatic Liver Tumor dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinicl, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products. Key Topics Covered:
For more information visit http://www.researchandmarkets.com/research/dhkjgr/hepatic_liver
|